Molecular targeting therapy of dyslipidemia
Hara, M.; Kinoshita, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 618-622
2012
ISSN/ISBN: 0047-1852 PMID: 23513913 Document Number: 659274
Document emailed within 1 workday
Related Documents
Demetter, P.; Maréchal, R.; Verset, L.; Salmon, I.; Bachet, J.-B.; Van Laethem, J.L. 2012: Molecular changes in pancreatic cancer: implications for molecular targeting therapy Acta Gastro-Enterologica Belgica 75(2): 210-214Tabe, Y. 2009: Molecular diagnosis of and molecular targeting therapy for leukemia Rinsho Byori. Japanese Journal of Clinical Pathology 57(2): 137-145
Uemura, H. 2012: Era of molecular targeting therapy in RCC Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 480-485
Nishioka, Y. 2013: I. Molecular targeting therapy and immunotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(8): 1004-1008
Mima, T.; Nakashima, Y.; Hanba, Y.; Ohya, M.; Negi, S.; Shigematsu, T. 2012: Molecular targeting therapy in rheumatoid arthritis Nihon Jinzo Gakkai Shi 54(5): 603-609
Naka, N. 2012: II. Possibility of molecular targeting therapy for musculoskeletal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 373-377
Fujii, M. 2013: IV. Molecular targeting therapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 867-870
Tahara, M. 2012: II. Molecular targeting therapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(7): 1055-1060
Okamoto, I. 2008: Molecular targeting therapy for treatment of non-small-cell lung carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(8): 1303-1309
Fujii, S.; Abe, M. 2012: Molecular targeting agents for multiple myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 518-523
Takashima, A.; Fukuda, H.; Shibata, T. 2010: Development for and clinical trials of molecular targeting drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 822-827
Van Adelsberg, J. 1998: Protein targeting: the molecular basis of vectorial transport in the kidney Seminars in Nephrology 18(2): 152-166
Kuzuya, T.; Tsuchiya, K.; Izumi, N. 2010: Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1883-1886
Arao, T.; Kudo, M.; Nishio, K. 2010: Searching for biological markers of molecular targeting treatment of liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1879-1882
Banerjee, A.Kumar. 2008: Changing face of dyslipidemia therapy Indian Heart Journal 60(3): 192-194
Cattin, L.; Spangano, F.; Fonda, M. 2012: Dyslipidemia: news in diagnosis and drug therapy Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 29 Suppl. 54: S5-13
Borgia, M.C.; Nardi, M.; Da Ros, S.; Castellano, V. 2007: Therapy of dyslipidemia in post-infarction: state of the art La Clinica Terapeutica 158(6): 523-532
Setterquist, R.A.; Smith, G.K.; Jones, R.; Fox, G.E. 1996: Diagnostic probes targeting the major sperm protein gene that may be useful in the molecular identification of nematodes Journal of Nematology 28(4 Suppl): 414-421
Ceccato, M.G.B.; Bonolo, P.F.; Souza Neto, A.I.; Araújo, F.S.; Freitas, M.I.F. 2011: Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil Brazilian Journal of Medical and Biological Research 44(11): 1177-1183
Ames, J.B.; Ikura, M.; Stryer, L. 2000: Molecular structure of membrane-targeting calcium sensors in vision: recoverin and guanylate cyclase-activating protein 2 Methods in Enzymology 316: 121-132